Manns MP - Search Results

1

Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses.

Zhao F, Hoechst B, Gamrekelashvili J, Ormandy LA, Voigtländer T, Wedemeyer H, Ylaya K, Wang XW, Hewitt SM, Manns MP, Korangy F, Greten TF. Zhao F, et al. Among authors: manns mp. J Immunol. 2012 Jun 15;188(12):6055-62. doi: 10.4049/jimmunol.1102918. Epub 2012 May 21. J Immunol. 2012. PMID: 22615204 Free PMC article.

2

Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes.

Greten TF, Korangy F, Neumann G, Wedemeyer H, Schlote K, Heller A, Scheffer S, Pardoll DM, Garbe AI, Schneck JP, Manns MP. Greten TF, et al. Among authors: manns mp. J Immunol Methods. 2002 Dec 20;271(1-2):125-35. doi: 10.1016/s0022-1759(02)00346-0. J Immunol Methods. 2002. PMID: 12445736

3

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo.

Scheffer SR, Nave H, Korangy F, Schlote K, Pabst R, Jaffee EM, Manns MP, Greten TF. Scheffer SR, et al. Among authors: manns mp. Int J Cancer. 2003 Jan 10;103(2):205-11. doi: 10.1002/ijc.10777. Int J Cancer. 2003. PMID: 12455034

4

[Acute hepatitis C--therapy with interferon alpha-2b]].

Wedemeyer H, Manns MP. Wedemeyer H, et al. Among authors: manns mp. Internist (Berl). 2002 Nov;43(11):1477-8. doi: 10.1007/s00108-002-0760-0. Internist (Berl). 2002. PMID: 12524927 German. No abstract available.

5

The German network of excellence for viral hepatitis (Hep-Net).

Manns MP, Meyer S, Wedemeyer H. Manns MP, et al. Hepatology. 2003 Sep;38(3):543-4. doi: 10.1002/hep.510380302. Hepatology. 2003. PMID: 12939578 No abstract available.

6

Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation.

Tillmann HL, Wedemeyer H, Manns MP. Tillmann HL, et al. Among authors: manns mp. J Hepatol. 2003;39 Suppl 1:S206-11. doi: 10.1016/s0168-8278(03)00364-7. J Hepatol. 2003. PMID: 14708705 Review. No abstract available.

7

Hepatitis B virus: where are we and where are we going?

Manns MP, Hadem J, Wedemeyer H. Manns MP, et al. Methods Mol Med. 2004;96:415-43. doi: 10.1385/1-59259-670-3:415. Methods Mol Med. 2004. PMID: 14762285 Review. No abstract available.

8

Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C.

Wedemeyer H, Jäckel E, Wiegand J, Cornberg M, Manns MP. Wedemeyer H, et al. Among authors: manns mp. Hepatology. 2004 May;39(5):1201-3. doi: 10.1002/hep.20221. Hepatology. 2004. PMID: 15122747 Review. No abstract available.

9

Long-term follow-up after successful interferon therapy of acute hepatitis C.

Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H. Wiegand J, et al. Among authors: manns mp. Hepatology. 2004 Jul;40(1):98-107. doi: 10.1002/hep.20291. Hepatology. 2004. PMID: 15239091

10

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.

Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP, Greten TF. Korangy F, et al. Among authors: manns mp. Clin Cancer Res. 2004 Jul 1;10(13):4332-41. doi: 10.1158/1078-0432.CCR-04-0181. Clin Cancer Res. 2004. PMID: 15240519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,468 results

Search Page

Filters